Quality of Sexual Life after Native Tissue versus Polypropylene Mesh Augmented Pelvic Floor Reconstructive Surgery

There are still controversies around reconstructive surgeries used in POP treatment. The aim of this study was to compare the QoSL after VNTR vs. TVM surgery due to POP via the use of PISQ-12 and FSFI questionnaires. The study included a group of 121 sexually active patients qualified for reconstruc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksandra Kamińska, Katarzyna Skorupska, Agnieszka Kubik-Komar, Konrad Futyma, Joanna Filipczak, Tomasz Rechberger
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/4f2327a508664e8a9eeca980881bd337
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:There are still controversies around reconstructive surgeries used in POP treatment. The aim of this study was to compare the QoSL after VNTR vs. TVM surgery due to POP via the use of PISQ-12 and FSFI questionnaires. The study included a group of 121 sexually active patients qualified for reconstructive surgery due to symptomatic POP, and 50 control. The average results of PISQ-12 before and after surgery were compared using the <i>t</i>-test. The significance of the mean differences in demographic groups was measured using the <i>t</i>-test for independent samples and one-way ANOVA. The results in the demographic groups were compared using the Mann–Whitney U test and the Kruskal–Wallis test. Fifty-eight women had VNTR, while 63 had TVM. Results of PISQ-12 revealed significant improvement in the sexual life after reconstructive surgery (27.24 vs. 32.43; <i>p</i> < 0.001, <i>t</i> = 8.48) both after VNTR and TVM. There were no significant differences in the assessment of the QoSL according to PISQ-12 and FSFI results between both analyzed groups of patients (PISQ-12: VNTR vs. TVM; <i>t</i>-test <i>p</i> = 0.19 and FSFI: VNTR vs. TVM; Mann–Whitney U test <i>p</i> = 0.54). VNTR is the treatment of choice in the case of uncomplicated primary POP.